Brand & Portfolio
Analytics
Strategic support for understanding customers’
needs and the strategies that maximize the value
of your brand and/or business unit.
needs and the strategies that maximize the value
of your brand and/or business unit.
Lifecycle Management
Offering solutions and insights at every stage of a product’s lifecycle.
Rosenblatt Life Science Consultants offers solutions and insights at every stage of a product’s lifecycle. From development to maturity, Rosenblatt Life Science Consultants utilizes strategic market research and established best practices to guide clients on market preparation, stakeholder influence, launch execution, and post-launch tracking and measurement.
New Product
Planning
From researching customer needs and developing a product concept to designing, testing, and launching the product, our New Product Planning analytics ensures that your organization can maximize the value of its new products and services.
Rosenblatt Life Science Consultants consultants are aware of market uncertainties and assist clients in assessing opportunities systematically and comprehensively, using a range of qualitative and quantitative research techniques. To assist clients, we help define, evaluate and plan for different scenarios, conduct quantitative and qualitative war games, and establish decision frameworks for these multifactorial decisions.
Promotional Response
Optimizing promotional ROI with advanced analytics that informs the spend level and mix of channels for each target group.
Rosenblatt Life Science Consultants enables you to optimize every phase of promotion through thoughtful metrics, advanced modeling, and strategic insights. Rosenblatt Life Science Consultants has extensive promotion response modeling capabilities to understand promotional sensitivities, design and build test scenarios and “what-if” models, and measure campaigns.
Real World
Evidence
The biopharmaceutical industry has firmly embraced the utilization of real-world data (RWD) and real-world evidence (RWE).
From the regulatory perspective, the value is to measure and evaluate the post-market safety of approved drugs.
From the commercial biopharma lens, the data provides a unique perspective on how, when, why and by whom drugs are utilized in a way not previously understood. The advent, use and now integration of longitudinal patient claims and electronic medical records has been a game changer. Large quantitative data sets of patient drug utilization can now provide insights to physician drug choices, patient compliance and persistence, drug switching and substitution and concomitant drug use. The type of available data, and thus analytics, is continually growing. Examples of RWD include data derived from electronic health records, medical claims data, data from product or disease registries, and data gathered from other sources, such as digital health technologies.
We deliver a broad & deep array of brand & business unit analytics services.
